Trajan Group Holdings Limited (ASX:TRJ)

Market Cap	61.04M -49.9%
Revenue (ttm)	169.52M +6.2%
Net Income	-1.38M
EPS	-0.01
Shares Out	152.59M
PE Ratio	n/a
Forward PE	10.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,825
Average Volume	52,060
Open	0.4000
Previous Close	0.4000
Day's Range	0.3950 - 0.4250
52-Week Range	0.3900 - 0.9700
Beta	0.42
RSI	34.18
Earnings Date	May 27, 2026

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology produ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 630
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRJ

Financial Performance

In fiscal year 2025, Trajan Group Holdings's revenue was 166.46 million, an increase of 7.38% compared to the previous year's 155.02 million. Losses were -4.46 million, -82.39% less than in 2024.